Display options
Share it on

Diagnostics (Basel). 2020 Sep 27;10(10). doi: 10.3390/diagnostics10100758.

Coagulation Profiles of Pulmonary Arterial Hypertension Patients, Assessed by Non-Conventional Hemostatic Tests and Markers of Platelet Activation and Endothelial Dysfunction.

Diagnostics (Basel, Switzerland)

Eleni Vrigkou, Argyrios E Tsantes, Petros Kopterides, Stylianos E Orfanos, Apostolos Armaganidis, Eirini Maratou, Evdoxia Rapti, Athanasios Pappas, Andreas G Tsantes, Iraklis Tsangaris

Affiliations

  1. Second Department of Critical Care Medicine, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Rimini 1, 12462 Athens, Greece.
  2. Laboratory of Hematology and Blood Bank Unit, "Attikon" University Hospital, Medical School, National and Kapodistrian University of Athens, Rimini 1, 12462 Athens, Greece.
  3. Laboratory of Clinical Biochemistry, "Attikon" University Hospital, Medical School, University of Athens, Rimini 1, 12462 Athens, Greece.

PMID: 32992591 PMCID: PMC7601126 DOI: 10.3390/diagnostics10100758

Abstract

Many pathophysiologic processes of pulmonary arterial hypertension (PAH), namely, excess vasoconstriction, vascular remodeling and in situ thrombosis, involve the coagulation cascade, and more specifically, platelets. The aim of this study was to globally assess coagulation processes in PAH, by using non-conventional hemostatic tests, along with markers of platelet activation and endothelial dysfunction. We studied 44 new PAH patients (22 with idiopathic PAH and 22 with connective tissue disease) and 25 healthy controls. The following tests were performed: platelet function analyzer-100 (PFA-100), light transmission aggregometry (LTA), rotational thromboelastometry (ROTEM), endogenous thrombin potential (ETP), serotonin, thromboxane A2 and p-selectin plasma levels, and von Willebrand antigen (VWF:Ag) and activity (VWF:Ac). Our results showed that PAH patients had diminished platelet aggregation, presence of disaggregation, defective initiation of the clotting process and clot propagation, and diminished thrombin formation capacity. Serotonin, thromboxane A2 and p-selectin levels were increased, and VWF:Ag and VWF:Ac decreased in the same population. The results of this study suggest that the platelets of PAH patients are activated and present functional abnormalities. The procoagulant activity, in general, appears to be impaired probably due to a sustained and prolonged activation of the procoagulant processes. Larger observational studies are warranted to confirm these laboratory findings.

Keywords: bloodcoagulation disorders; p-selectin; platelet aggregation; pulmonary arterial hypertension; serotonin; thrombin; thromboxane A2; von Willebrand

References

  1. Cochrane Database Syst Rev. 2014 Jun 03;(6):CD010695 - PubMed
  2. Am J Med. 1980 Aug;69(2):235-40 - PubMed
  3. Eur J Pharmacol. 2020 Oct 27;:173658 - PubMed
  4. Eur Respir J. 2013 Apr;41(4):872-8 - PubMed
  5. Br J Haematol. 2018 Oct;183(2):267-275 - PubMed
  6. Can J Cardiol. 2014 Aug;30(8):879-87 - PubMed
  7. Curr Hypertens Rep. 2016 Jun;18(6):47 - PubMed
  8. Chest. 2015 Feb;147(2):529-537 - PubMed
  9. Heart Lung. 2014 Nov-Dec;43(6):569-73 - PubMed
  10. Front Med (Lausanne). 2019 Feb 05;6:7 - PubMed
  11. PLoS One. 2013 Dec 02;8(12):e82628 - PubMed
  12. Clin Appl Thromb Hemost. 2006 Jul;12(3):305-10 - PubMed
  13. Am J Hematol. 2014 Feb;89(2):228-32 - PubMed
  14. Thromb Haemost. 2019 Jul;119(7):1154-1161 - PubMed
  15. Clin Appl Thromb Hemost. 2002 Oct;8(4):353-8 - PubMed
  16. Korean J Anesthesiol. 2019 Aug;72(4):297-322 - PubMed
  17. Clin Chest Med. 2018 Sep;39(3):595-603 - PubMed
  18. Diseases. 2018 May 16;6(2): - PubMed
  19. Eur Heart J. 2016 Jan 1;37(1):67-119 - PubMed
  20. Semin Thromb Hemost. 2006 Sep;32(6):589-604 - PubMed
  21. Braz J Med Biol Res. 2011 Dec;44(12):1269-75 - PubMed
  22. Ann Am Thorac Soc. 2016 Jan;13(1):25-30 - PubMed
  23. Transfus Med Hemother. 2010;37(5):237-246 - PubMed
  24. Platelets. 2019;30(5):646-651 - PubMed
  25. Circulation. 1984 Oct;70(4):580-7 - PubMed
  26. Pulm Circ. 2015 Mar;5(1):90-100 - PubMed
  27. Thromb Res. 2010 Dec;126(6):e418-22 - PubMed
  28. J Atheroscler Thromb. 2019 Apr 1;26(4):303-314 - PubMed
  29. Pulm Circ. 2018 Apr-Jun;8(2):2045894018759125 - PubMed
  30. Int J Clin Exp Pathol. 2015 Jun 01;8(6):7189-95 - PubMed
  31. Anaesthesia. 2019 Aug;74(8):1063 - PubMed
  32. Hamostaseologie. 2020 Aug;40(3):348-355 - PubMed
  33. Clin Transplant. 2013 Mar-Apr;27(2):E101-8 - PubMed
  34. Pediatr Res. 2015 Mar;77(3):455-62 - PubMed
  35. Thromb Res. 2012 Sep;130(3):424-8 - PubMed
  36. Lancet Haematol. 2016 Sep;3(9):e426-36 - PubMed
  37. Adv Med Sci. 2018 Sep;63(2):312-316 - PubMed
  38. J Am Coll Cardiol. 2015 May 12;65(18):1976-97 - PubMed
  39. Platelets. 2001 Aug;12(5):261-73 - PubMed
  40. Front Med (Lausanne). 2018 Jun 06;5:175 - PubMed
  41. Platelets. 2018 Nov;29(7):656-661 - PubMed

Publication Types